Skip to main content
. 2021 Mar 5;22(5):2618. doi: 10.3390/ijms22052618

Figure 3.

Figure 3

Clinical improvement of AD and AA by dupilumab treatment. (ad) Representative case of AA with extrinsic AD before and 6 months after dupilumab therapy. (e,f) Changes of EASI scores (e) and SALT scores (f) in 6 patients with extrinsic AD and AA before and 6 months after dupilumab therapy. (gj) Representative case of AA with extrinsic AD before and 6 months after dupilumab therapy. (k) The CXCR3/CCR4 ratio in the AA patients with extrinsic AD.